We were delighted to speak with Professor Jeremy Adler (Michigan Medicine, University of Michigan, Ann Arbor, MI, USA) around his talk around the findings from the validation study of the Simplified Endoscopic Mucosal Assessment of Crohn’s Disease (SEMA-CD).
The abstract entitled ‘VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA’ was presented at the virtual 2022 Crohn’s & Colitis Congress, 20-22 January, 2022.
Questions
- Why is there a need for an endoscopic mucosal assessment in clinical practice? (0:23)
- Could you tell us a little about the Simplified Endoscopic Mucosal Assessment of CD (SEMA-CD)? (1:24)
- What were the aims and design of your validation study? (2:08)
- What were the findings of the study? (2:48)
- What are the implications of these findings for clinical practice and future clinical trial design? (5:22)
Disclosures: Jeremy Adler discloses consulting for Janssen Research & Development, LLC; and receiving grant/ research support from Janssen Research & Development, LLC.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the virtual Crohn’s & Colitis Congress 2022.
